Detection Index Algorithm for Somatic Mutation Efficacy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting molecular and cellular changes in heterogeneous cell populations, such as somatic mutations, are inadequate due to reliance on sensitivity and specificity parameters that do not accurately reflect the efficacy of detection, particularly in heterogeneous cell populations, leading to potential false negatives and false positives in targeted therapies.
Innovation Solution
A new algorithm, Detection Index (DI), is introduced, which combines the number of copies of the mutant allele and the ratio of mutant to wild-type alleles to evaluate the efficacy of detection, providing a more accurate measure of detection efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If sensitivity and specificity parameters are used to evaluate detection efficacy, then the evaluation framework is simple and established, but the detection accuracy in heterogeneous cell populations is insufficient leading to false negatives and false positives
Solution Approach 1:
The patent changes the evaluation parameters from traditional sensitivity and specificity to a new composite parameter called Detection Index (DI). The DI incorporates multiple factors including mutant allele frequency, wild-type allele frequency, and detection limit to provide a more comprehensive and accurate evaluation of detection efficacy in heterogeneous cell populations, thereby reducing false results.
2Measurement precision
If traditional sensitivity evaluation is used, then the assessment method is straightforward, but it cannot accurately reflect detection efficacy when target concentration is low in heterogeneous populations
Solution Approach 1:
The Detection Index is segmented into multiple independent components: mutant allele frequency, wild-type allele frequency, and detection limit. Each component can be calculated and optimized separately, then combined to provide a comprehensive evaluation. This segmentation allows for systematic improvement of each parameter while maintaining overall evaluation accuracy.
Solution Approach 2:
The Detection Index functions as a composite evaluation metric that integrates multiple parameters (sensitivity, specificity, allele frequencies, detection limit) into a single comprehensive measure. This composite approach provides a more robust and accurate assessment of detection efficacy compared to single-parameter evaluation methods.
3Reliability
If standard detection methods are applied, then the workflow is simple and fast, but the ability to detect low-concentration somatic mutations in heterogeneous populations is insufficient
Solution Approach 1:
The patent replaces traditional mechanical/chemical detection approaches with a computational evaluation system. The Detection Index uses mathematical modeling and algorithmic calculation to assess detection efficacy, substituting physical detection limitations with computational analysis that can accurately evaluate even low-concentration targets in heterogeneous populations.
Data Source
AI summary
Somatic mutations are associated with cancer progression and treatment using targeted therapies. Somatic mutations are not inherited and could be present at low concentrations in biopsy samples. Hence, there is a need for more sensitive assays to detect these changes in the presence of heterogeneous cell populations. The efficacy of such detection is determined by two factors; the ability to detect a minimum number of copies of the target mutation in the sample (Lower limit of detection), and the ratio of target mutation to that of wild-type in the sample (Tumor content). A new algorithm Detection Index (DI) is formulated to evaluate the efficacy of detection for a molecular testing method.